Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tazaki

Showing results (41-50 of 260) with videos related to

Pageof 26
Sort By:
Urologia Internationalis|January 1, 1989
Renal cell carcinoma presenting as Budd-Chiari syndromeY Nakajima, S Baba, T Nagahama, et al.
Urology|December 1, 1984
Human lymphoblastoid interferon therapy for advanced renal cell carcinomaK Marumo, M Murai, M Hayakawa, et al.
American Journal of Industrial Medicine|January 1, 1982
Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workersN Yamaguchi, H Tazaki, T Okubo, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1991
[Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice]T Shibayama, M Tachibana, H Tazaki, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1988
[Studies on stimulation of immunological responses resulting from intravesical BCG instillation in patients with bladder carcinomas]M Tachibana, S Jitsukawa, N Deguchi, et al.
The Keio Journal of Medicine|April 1, 1981
Retrograde brushing to the urothelial tumors of the upper urinary tract for early diagnosis and treatmentM Hayakawa, S Jitsukawa, H Kinoshita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 1, 1992
[Analysis of early and late complications and their origins in Kock continent urinary reservoir following technical modification]M Tachibana, N Deguchi, S Jitsukawa, et al.
Progress in Clinical and Biological Research|January 1, 1989
Treatment of renal cell carcinoma with systemic administration of intermediate doses of recombinant human interleukin-2 alone. Recombinant Human Interleukin-2 (S-6820) Research Group on Renal Cell CarcinomaY Aso, H Tazaki, T Umeda, et al.
Bioscience, Biotechnology, and Biochemistry|December 14, 1999
1,2-Hydride Shift in the Biosynthesis of Pinguisane-type SesquiterpenesH Tazaki, T Iwasaki, Y Kawakami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 6, 2013
Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in miceK Marumo, M Oya, M Murai, et al.
Pageof 26

Showing results (41-50 of 260) with videos related to

Sort By:
Pageof 26
Urologia Internationalis|January 1, 1989
Renal cell carcinoma presenting as Budd-Chiari syndromeY Nakajima, S Baba, T Nagahama, et al.
Urology|December 1, 1984
Human lymphoblastoid interferon therapy for advanced renal cell carcinomaK Marumo, M Murai, M Hayakawa, et al.
American Journal of Industrial Medicine|January 1, 1982
Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workersN Yamaguchi, H Tazaki, T Okubo, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1991
[Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice]T Shibayama, M Tachibana, H Tazaki, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1988
[Studies on stimulation of immunological responses resulting from intravesical BCG instillation in patients with bladder carcinomas]M Tachibana, S Jitsukawa, N Deguchi, et al.
The Keio Journal of Medicine|April 1, 1981
Retrograde brushing to the urothelial tumors of the upper urinary tract for early diagnosis and treatmentM Hayakawa, S Jitsukawa, H Kinoshita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 1, 1992
[Analysis of early and late complications and their origins in Kock continent urinary reservoir following technical modification]M Tachibana, N Deguchi, S Jitsukawa, et al.
Progress in Clinical and Biological Research|January 1, 1989
Treatment of renal cell carcinoma with systemic administration of intermediate doses of recombinant human interleukin-2 alone. Recombinant Human Interleukin-2 (S-6820) Research Group on Renal Cell CarcinomaY Aso, H Tazaki, T Umeda, et al.
Bioscience, Biotechnology, and Biochemistry|December 14, 1999
1,2-Hydride Shift in the Biosynthesis of Pinguisane-type SesquiterpenesH Tazaki, T Iwasaki, Y Kawakami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 6, 2013
Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in miceK Marumo, M Oya, M Murai, et al.
Pageof 26